dienogest has been researched along with Peritoneal Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angioni, S; Barbasetti Di Prun, A; Barbera, V; Belloni, GM; Pietropaolo, G; Pino, I; Vignali, M | 1 |
| Fukami, T; Matsushima, T; Shinmura, H; Takeshita, T | 1 |
| Andou, M; Ebisawa, K; Hada, T; Kanno, K; Matsumoto, T; Nakajima, S; Ota, Y; Shirane, A; Yamanaka, A; Yanai, S | 1 |
| Fukaya, T; Izumiya, C; Maeda, N; Matsushima, S; Mita, S; Shimizu, Y; Taniguchi, K | 1 |
4 other study(ies) available for dienogest and Peritoneal Diseases
| Article | Year |
|---|---|
Effect of Dienogest therapy on the size of the endometrioma.
Topics: Adult; Dysmenorrhea; Dyspareunia; Endometriosis; Endometrium; Female; Humans; Italy; Middle Aged; Nandrolone; Organ Size; Pelvic Pain; Peritoneal Diseases; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2020 |
Successful treatment of peritoneal inclusion cysts with dienogest: two case reports.
Topics: Cysts; Endometriosis; Humans; Nandrolone; Peritoneal Diseases | 2022 |
Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
Topics: Endometriosis; Female; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Diseases; Pain; Peritoneal Diseases; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2017 |
Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis.
Topics: Adult; Ascitic Fluid; Cells, Cultured; Endometriosis; Female; HLA-DR Antigens; Hormone Antagonists; Humans; Macrophages; Nandrolone; Peritoneal Diseases; Tumor Necrosis Factor-alpha | 2014 |